The DOI matches its Crossref record.
Propranolol in the Control of Schizophrenic Symptoms
Open accessAbstract
All schizophrenic symptoms remitted completely in six out of 14 adults who had not responded to phenothiazine drugs and who were then given propranolol. Another patient improved markedly and four improved moderately. Two had minimal or transient improvement, and one left hospital unchanged after a short, severe, toxic reaction. The six with complete remissions all began to improve within a few days of starting propranolol and the florid symptoms remitted completely after three to 26 days. They were stabilized on a daily dose of 500-3,500 mg of propranolol and at the time of writing had remained well for up to six months. Two patients who stopped propranolol after their symptoms remitted relapsed severely within a few days. Toxic effects (ataxia, visual hallucinations, and confusional states) were related to the rate of increase rather than to the absolute dose of propranolol. After the procedure was modified unwanted effects were usually mild or absent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Westerink, B. C., & Korf, J. (1976) · The Lancet · doi:10.1016/s0140-6736(76)90053-2 · Cited by 460
Propranolol Treatment for Childhood Posttraumatic Stress Disorder, Acute Type: A Pilot Study
Famularo, R. (1988) · American Journal of Diseases of Children · doi:10.1001/archpedi.1988.02150110122036 · Cited by 296
Direct evidence for an interaction of β-adrenergic blockers with the 5-HT receptor
MIDDLEMISS, D. N., BLAKEBOROUGH, L., & LEATHER, S. R. (1977) · Nature · doi:10.1038/267289a0 · Cited by 271
Propranolol for the treatment of anxiety disorders: Systematic review and meta-analysis
Steenen, S. A., van Wijk, A. J., van der Heijden, G. J., van Westrhenen, R., de Lange, J., & de Jongh, A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881115612236 · Cited by 237
Metadata
- Authors
- Yorkston, N. J., Zaki, S. A., Malik, M. K. U., Morrison, R. C., & Havard, C. W. H.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1974-12-14
- Volume
- 4
- Issue
- 5945
- Pages
- 633-635
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2015969102
- Cited by
- 159
- References
- 0
- FWCI
- 23.14
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Propranolol in the Control of Schizophrenic Symptoms. https://app.cochat.ai/papers/10.1136/bmj.4.5945.633
- The paper
- Yorkston, N. J., Zaki, S. A., Malik, M. K. U., Morrison, R. C., & Havard, C. W. H. (1974). Propranolol in the Control of Schizophrenic Symptoms. BMJ. https://doi.org/10.1136/bmj.4.5945.633
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.